CPT® Code 0609T

Magnetic resonance spectroscopy, determination and localization of discogenic pain (cervical, thoracic, or lumbar); acquisition of single voxel data, per disc, on biomarkers (ie, lactic acid, carbohydrate, alanine, laal, propionic acid, proteoglycan, and collagen) in at least 3 discs

Magnetic resonance spectroscopy (MRS) is a sophisticated imaging technique that allows for the assessment of biochemical processes within the body, particularly in the context of spinal health. This procedure is specifically designed to identify and localize discogenic pain, which is pain originating from the intervertebral discs in the cervical, thoracic, or lumbar regions of the spine. By acquiring single voxel data from at least three discs, MRS can analyze various biomarkers that are indicative of disc health and degeneration. These biomarkers include lactic acid, carbohydrates, alanine, propionic acid, proteoglycan, and collagen, each of which plays a crucial role in understanding the biochemical environment of the discs. The significance of MRS lies in its ability to provide a noninvasive evaluation of disc integrity and the biochemical changes associated with pain. Chronic low back pain, a prevalent condition affecting millions globally, often leads to significant disability and is a common reason for opioid prescriptions. MRS helps in quantifying the degree of degeneration by measuring the concentrations of specific metabolites, which can inform treatment decisions and predict surgical outcomes. The technique leverages the unique resonant frequencies of different molecules when subjected to a strong magnetic field, allowing for the differentiation of various chemical structures. This detailed analysis aids in calculating the potential for pain based on the ratios of these biomarkers, thereby enhancing the understanding of disc disease severity and progression.